Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT04164849

Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid

Sponsor: Oslo University Hospital

Interventions 5-aminolevulinic acid Blue light photopheresis Continuous Mononuclear Cell Collection (CMNC) Transfusion

Updated 9 times since 2019 Last updated: Jan 29, 2024 Started: Nov 22, 2019 Primary completion: Oct 31, 2023 Completion: Oct 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Crohn Disease and is currently completed. Oslo University Hospital leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Feb 2024 — Jul 2024 [monthly]

Completed PHASE1_PHASE2

Status: Recruiting → Completed
Feb 2023 — Feb 2024 [monthly]

Recruiting PHASE1_PHASE2
Apr 2022 — Feb 2023 [monthly]

Recruiting PHASE1_PHASE2

▶ Show 4 earlier versions

Feb 2021 — Apr 2022 [monthly]

Recruiting PHASE1_PHASE2
Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE1_PHASE2
Jan 2020 — Jan 2021 [monthly]

Recruiting PHASE1_PHASE2
Dec 2019 — Jan 2020 [monthly]

Recruiting PHASE1_PHASE2

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital
University Hospital, Akershus

Data source: University Hospital, Akershus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lorenskog, Norway